U.S. Top High Growth Tech & AI Stocks - Spotless Financials

Fabrinet

Market Cap: US$25.2b

Provides optical packaging and precision optical, electro-mechanical, and electronic manufacturing services in North America, the Asia-Pacific, and Europe.

AppLovin

Market Cap: US$161.8b

Provides end-to-end artificial intelligence-powered advertising solutions for businesses in the United States and internationally.

Reddit

Market Cap: US$27.3b

Operates a digital community in the United States and internationally.

Krystal Biotech

Market Cap: US$8.8b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Marker Therapeutics

Market Cap: US$24.3m

A clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States.

Sandisk

Market Cap: US$219.0b

Develops, manufactures, and sells data storage devices and solutions using NAND flash technology in the United States, Europe, the Middle East, Africa, Asia, and internationally.

Palantir Technologies

Market Cap: US$328.1b

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally.

KVH Industries

Market Cap: US$227.9m

Designs, develops, manufactures, and markets mobile connectivity and managed services for the marine and land mobile markets.

Tenaya Therapeutics

Market Cap: US$167.6m

A clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States.

Zscaler

Market Cap: US$29.3b

Operates as a cloud security company worldwide.

Circle Internet Group

Market Cap: US$28.1b

Operates as a platform, network, and market infrastructure for stablecoin and blockchain applications.

Gorilla Technology Group

Market Cap: US$455.7m

Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.

Intellia Therapeutics

Market Cap: US$1.8b

Operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.

Quince Therapeutics

Market Cap: US$17.9m

A biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.

HubSpot

Market Cap: US$10.3b

Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.

CrowdStrike Holdings

Market Cap: US$168.9b

Provides cybersecurity solutions in the United States and internationally.

Kiniksa Pharmaceuticals International

Market Cap: US$4.1b

A biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.

Larimar Therapeutics

Market Cap: US$360.1m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Society Pass

Market Cap: US$559.7k

Acquires and operates fintech and e-commerce platforms and mobile applications for consumers and merchants in Indonesia, Vietnam, the Philippines, Singapore, the United States, Thailand, and Malaysia.

MediciNova

Market Cap: US$68.9m

A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.

Rumble

Market Cap: US$2.8b

Provides video sharing and cloud services platform in the United States, Canada, and internationally.

Neurocrine Biosciences

Market Cap: US$15.8b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Klaviyo

Market Cap: US$4.5b

Provides a cloud-based software-as-a-service platform in the United States, rest of the Americas, the Asia-Pacific, the United Kingdom, rest of Europe, the Middle East, and Africa.

Zeta Global Holdings

Market Cap: US$4.7b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.

Samsara

Market Cap: US$18.2b

Provides solutions to connect physical operations data to its connected operations platform in the United States and internationally.

Anavex Life Sciences

Market Cap: US$249.8m

Operates as a biopharmaceutical company.

Rezolute

Market Cap: US$339.5m

A late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States.

Digi Power X

Market Cap: US$723.2m

An energy infrastructure company, develops data centers to drive the expansion of energy assets in the United States.

Calix

Market Cap: US$2.5b

Engages in the provision of cloud and software platforms, and systems and services in the United States, rest of Americas, Europe, the Middle East, Africa, and the Asia Pacific.

LightPath Technologies

Market Cap: US$978.2m

Designs, develops, manufactures, and distributes optical systems and assemblies in the United States.

Clear Secure

Market Cap: US$8.0b

Operates a secure identity platform under the CLEAR brand name primarily in the United States.

SELLAS Life Sciences Group

Market Cap: US$1.4b

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Glimpse Group

Market Cap: US$17.1m

An immersive technology company provides enterprise focused virtual reality (VR), augmented reality (AR), and spatial computing software and services in the United States.

Gyre Therapeutics

Market Cap: US$553.7m

A pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.

MNTN

Market Cap: US$653.8m

Operates a technology platform that brings performance marketing to Connected TV.

Annexon

Market Cap: US$870.0m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.